KRAS and non-small cell lung carcinoma: However, analysis using TIMER 2.0 [97] shows that the levels of PPARγ mRNA are not altered in KRAS-mutated NSCLC compared with wild-type, while the expression of PPARδ appears to be decreased in the LUAD subtype when KRAS is mutated.